SCHEMBL5202875

SCHEMBL5202875

CC([C@@H](Cc1ccc(Cl)cc1)c1cccc(C#N)c1)N(C(=O)C1CCCC1)c1cccnc1

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 20/20 0.49
CNR2 P34972 15/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202911 0.90 CNR1 (0.61) CNR1CNR2
SCHEMBL5203347 0.90 CNR1 (0.58) CNR1CNR2
SCHEMBL5200571 0.89 CNR1 (0.60) CNR1CNR2
SCHEMBL5201336 0.89 CNR1 (0.48) CNR1CNR2
SCHEMBL5204011 0.88 CNR1 (0.61) CNR1CNR2
SCHEMBL5201208 0.88 CNR1 (0.61) CNR1CNR2
SCHEMBL5200439 0.87 CNR1 (0.47) CNR1CNR2
SCHEMBL5206303 0.87 CNR1 (0.42) CNR1CNR2
SCHEMBL5203082 0.87 CNR1 (0.51) CNR1CNR2
SCHEMBL5202740 0.87 CNR1 (0.54) CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490043-A4 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO INC (US) 2007-05-30 EP disclosed
EP-1490043-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS Merck & Co., Inc. (US) 2004-12-29 EP disclosed
WO-2003082190-A2 SPIROCYCLIC AMIDES AS CANNABINOID RECEPTOR MODULATORS MERCK & CO., INC. (US) 2003-10-09 WO disclosed